Title (fr)

Publication

Application

Priority

GB 9607110 A 19960404

US 9704259 W 19970320

US 1416796 P 19960326

Abstract (en)

[origin: WO9735571A1] This invention provides compounds of formula (I) and pharmaceutically acceptable salts an solvates thereof, characterized that the compound is in particulate form and has a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula (I), and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.